IndustryCompany release

Eupraxia Pharmaceuticals sets up at-the-market share sales program with Jefferies under US$300M shelf

Eupraxia Pharmaceuticals Inc. (EPRX) · Tue 10 Nov 2026

Eupraxia Pharmaceuticals entered an Open Market Sale Agreement dated November 10, 2026 with Jefferies LLC and Jefferies Securities, Inc. It allows the company to issue and sell common shares from time to time on Nasdaq and the TSX, at a 3% selling commission. The program is drawn from the company's Canadian short form base shelf prospectus of up to US$300 million, with the British Columbia Securities Commission as principal regulator.

Company's press release (SEC filing): Eupraxia Pharmaceuticals Inc. ↗

Brief written by VigiEye from the company's press release filed with the SEC. Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →